Bolingas, Edsel D.

HRN: 13-24-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2025
CEFTRIAXONE 1G (VIAL)
10/17/2025
10/24/2025
IV
2g
Daily
Nonhealing Wound, RCI
Waiting Final Action 
10/17/2025
MUPIROCIN 2%, 15G (TUBE)
10/17/2025
10/24/2025
TOPICAL
Apply Directly
Every 12 Hours
Multiple Abrasions
Waiting Final Action 
10/17/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2025
10/23/2025
IV
600 Mg
Q 8 Hours
Mva
Waiting Final Action 
10/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/18/2025
10/25/2025
IV
4.5g
Q6
Non Healing Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: